DKSH (DKSH) CMD 2024 summary

Strategic transformation, direction, and growth outlook

• Achieved a 50% core EBIT uplift since 2019, with a 60 basis point margin increase, 28 acquisitions, and expansion into Australia, New Zealand, Europe, and North America.

• Midterm roadmap targets accelerated growth, continuous margin improvement of at least 10 basis points annually, and increased M&A, leveraging structural tailwinds in Asia-Pacific and operational excellence.

• Focus on high-margin business, digitalization, sustainability, and a high-performance culture, with over 60% of distribution centers digitized and significant AI initiatives underway.

• Asset-light business model with strong cash generation, disciplined capital allocation, and a progressive dividend policy maintained for 12 consecutive years.

• Ambitious M&A pipeline, aiming for larger, transformational deals, with a comfort level of up to 2–2.5x leverage and over CHF 900M invested since 2019.

Financial performance and guidance

• Core EBIT CAGR of 10.1% and free cash flow CAGR of 15.9% since 2019, with EBIT margin improved from 2.4% in 2019 to 3.0% in 2023.

• Net working capital as a percentage of net sales reduced by 170 basis points since 2019, driving strong cash generation.

• Zero net debt and equity ratio of 31.8% as of December 2023.

• Targeting 10 basis points annual EBIT margin expansion, with each business unit budgeting for margin improvement into 2025.

• Continued focus on high cash conversion (at least 90% of PAT), asset-light operations, and disciplined M&A for margin-accretive growth.

Business unit strategies and achievements

• Healthcare: Delivered over 40% core EBIT growth since 2019, expanded to 16 markets, focusing on commercial outsourcing, own brands, and value-added services, with strong growth in VIP markets and new agency contracts.

• Technology: Streamlined portfolio to focus on scientific solutions and high-tech industries, achieving double-digit CAGR and 60 basis point EBIT margin improvement since 2019, with a strong M&A pipeline in APAC.

• Consumer Goods: Optimized client portfolio for higher margins, achieved 2.5% margin in H1 2024, and defined strategy for profitable growth and accelerated M&A.

• Performance Materials: Achieved 14.1% CAGR at constant exchange rates, net sales 1.7x since 2019, expanded globally through organic growth and 12 acquisitions, and increased EBIT/EBITDA ratio to 8.7%.

• All business units contribute to core EBIT growth, with targeted M&A and operational excellence driving results.